Regranex Gel 0.01% Gel
Product Images NDC 85822-734

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Regranex Gel 0.01% (NDC 85822-734). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lrm Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Image (25093 15g Carton V5)

This text provides detailed information about a prescription medication called Regranex gel, which contains the active ingredient becaplermin. It includes instructions for storage, usage, and precautions such as refraining from freezing and keeping out of reach of children. The product is registered trademarked and manufactured by Lynch Regenerative Medicine, LLC. Instructions for opening and closing the tube securely are also given. Make sure to follow the provided dosage and administration guidelines.*

FDA Label Image

Tube Image (25093 15g Tube V5)

This text provides information on a gloss varnish with color codes, dimensions, substrates, and additional details related to a product called Regranex. It includes color specifications, like Purple 2112 and Teal 2223, along with corner details and a job number (#25093). The description highlights details such as instructions for use, ingredients, administration, and storage instructions. Additionally, it mentions the product's registration trademark and warning about keeping it away from children. The text contains technical elements like diameter, slit width, and weight (159).*

FDA Label Image

Package Insert Figure 1 (Regranex Package Insert Figure 1)

FDA Label Image

Package Insert Table 3 (Regranex Package Insert Table 3)

This is a table presenting the percentage of complete diabetic lower extremity ulcer healing over time for a study comparing the effects of REGRANEX Gel 0.01% and Placebo. The percentages are shown for each week from Week 2 to Week 20. The data indicates a gradual increase in healing rates for both treatments over the 20-week period.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.